The pro-apoptotic ARTS/Sept4 protein is significantly reduced in post-mortem brains from schizophrenic patients

Schizophrenia Research

Volumn 96, Issue 1-3, 2007, Pages 257-266

  Gottfried, Yossi ^a   Rotem, Asaf ^a   Klein, Ehud ^a   Larisch, Sarit ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Apoptosis; ARTS; Frontal cortex; Neurons; Schizophrenia

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN ARTS; PROTEIN SEPT4; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; AUTOPSY; BIPOLAR DISORDER; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR DEPRESSION; MALE; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS; AUTOPSY; BIOLOGICAL MARKERS; CELL SURVIVAL; CYTOSKELETAL PROTEINS; FRONTAL LOBE; GTP PHOSPHOHYDROLASES; HUMANS; IN SITU NICK-END LABELING; POSTMORTEM CHANGES; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 34848908637     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.05.031     Document Type: Article

References (45)

1. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., and Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 48 11 (1999) 996-1001
2. Benes F.M., Vincent S.L., and Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol. Psychiatry 50 6 (2001) 395-406
3. Benes F.M., Walsh J., Bhattacharyya S., Sheth A., and Berretta S. DNA fragmentation decreased in schizophrenia but not bipolar disorder. Arch. Gen. Psychiatry 60 4 (2003) 359-364
4. Castle D.J., McGrath J., and Kulkarni J. Women and Schizophrenia (2000), Cambridge University Press, Cambridge, England
5. Cecil K.M., Lenkinski R.E., Gur R.E., and Gur R.C. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology 20 (1999) 131-140
6. Childers S.E., and Harding C.M. Gender, premorbid social functioning, and long-term outcome in DSM-III schizophrenia. Schizophr. Bull. 16 2 (1990) 309-318
7. Coyle J.T., Tsai G., and Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann. N. Y. Acad. Sci. 1003 (2003) 318-327
8. Elhasid R., Sahar D., Merling A., Zivony Y., Rotem A., Ben-Arush M., and Larich S. Mitochondrial pro-apoptotic ARTS protein is lost in the majority of acute lymphoblastic leukemia patients. Oncogene 23 32 (2004) 5468-5475
9. Goldstein J.M., Goodman J.M., Seidman L.J., Kennedy D.N., Makris H., Lee H., Tourville J., Caviness Jr. V.S., Faraone S.V., and Tsuang M.T. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch. Gen. Psychiatry 56 (1998) 537-547
10. Gottfried Y., Rotem A., Lotan R., Steller H., and Larisch S. The mitochondrial ARTS protein promotes apoptosis through targeting XIAP. EMBO J. 23 7 (2004) 1627-1635
11. Gottfried Y., Voldavsky E., Yodko L., Sabo E., Ben-Itzhak O., and Larisch S. Expression of the pro-apoptotic protein ARTS in astrocytic tumors: correlation with malignancy grade and survival rate. Cancer 101 11 (2004) 2614-2621
12. Hall P.A., and Russell S.E. The pathobiology of the septin gene family. J. Pathol. 204 4 (2004) 489-505
13. Hengartner M.O. The biochemistry of apoptosis. Nature 12 (2000) 770-776
14. Hipfner D.R., and Cohen S.M. Connecting proliferation and apoptosis in development and disease. Nat. Rev., Mol. Cell. Biol. 5 10 (2004) 805-815
15. Jarskog L.F. Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations. Curr. Opin. Psychiatry 19 3 (2006) 307-312
16. Jarskog L.F., Gilmore J.H., Selinger E.S., and Lieberman J.A. Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol. Psychiatry 48 7 (2000) 641-650
17. Jarskog L.F., Selinger E.S., Lieberman J.A., and Gilmore J.H. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am. J. Psychiatry 161 1 (2004) 109-115
18. Jeste D.V., and Lohr J.B. Hippocampal pathologic findings in schizophrenia: a morphometric study. Arch. Gen. Psychiatry 46 (1995) 1019-1024
19. Kaplan H.I., and Sadock B.J. Comprehensive Textbook of Psychiatry. 6TH edition (1995), Wiliams and Wilkins, Baltimore
20. Kozlovsky N., Bleaker R.H., and Agam G. GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur. Neuropsychopharmacol. 12 1 (2002) 13-25
21. Kubicki M., Shenton M.E., Salisbury D.F., Hirayasu Y., Kasai K., Kikinis R., Jolesz F.A., and McCarley R.W. Voxel-based morphometric analysis of gray matter in first episode schizophrenia. NeuroImage 17 (2002) 1711-1719
22. Larisch S., Yi Y., Lotan R., Kerner H., Eimerl S., Tony Parks W., Gottfried Y., Birkey Reffey S., de Caestecker M.P., Danielpour D., Book-Melamed N., Timberg R., Duckett C.S., Lechleider R.J., Steller H., Orly J., Kim S.J., and Roberts A.B. ARTS, a novel mitochondrial septin-like protein, mediates apoptosis dependent on its P-loop motif. Nat. Cell Biol. 2 12 (2000) 915-921
23. Larisch-Bloch S., Danielpour D., Roche N.S., Lotan R., Hsing A.Y., Kerner H., Hajouj T., Lechleider R.J., and Roberts A.B. Selective loss of the transforming growth factor-beta apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cells. Cell Growth Differ. 11 1 (2000) 1-10
24. Laruelle M., Kegeles L.S., and Abi-Dargham A. Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann. N. Y. Acad. Sci. 1003 (2003) 138-158
25. Leung A., and Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr. Scand., Suppl. 401 (2000) 3-38
26. Lotan R., Rotem A., Gonen H., Finberg J.P., Kemeny S., Steller H., Ciechanover A., and Larisch S. Regulation of the proapoptotic ARTS protein by ubiquitin-mediated degradation. J. Biol. Chem. 280 27 (2005) 25802-25810
27. Macara I.G., Baldarelli R., Field C.M., Glotzer M., Hayashi Y., Hsu S.C., Kennedy M.B., Kinoshita M., Longtine M., Low C., Maltais L.J., McKenzie L., Mitchison T.J., Nishikawa T., Noda M., Petty E.M., Peifer M., Pringle J.R., Robinson P.J., Roth D., Russell S.E., Stuhlmann H., Tanaka M., Tanaka T., Trimble W.S., Ware J., Zeleznik-Le N.J., and Zieger B. Mammalian septins nomenclature. Mol. Biol. Cell 13 (2002) 4111-4113
28. Margolis R.L., Chuang D.M., and Post R.M. Programmed cell death: implications for neuropsychiatric disorders. Biol. Psychiatry 35 12 (1994) 946-956
29. Martínez C., Miguel A., Sanjuan M.A., Dent J.A., Karlsson L., and Ware J. Human septin-septin interactions as a prerequisite for targeting septin complexes in the cytosol. Biochem. J. 382 Pt 3 (2004) 783-791
30. Moriarty P.J., Lieber D., Bennett A., White L., Parrella M., Harvey P.D., and Davis K.L. Gender differences in poor outcome patients with lifelong schizophrenia. Schizophr. Bull. 27 1 (2001) 103-113
31. Nasser E.H., Walders N., and Jenkins J.H. The experience of schizophrenia: what's gender got to do with it? A critical review of the current status of research on schizophrenia. Schizophr. Bull. 28 2 (2002) 351-362
32. Olney J.W., and Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52 12 (1995) 998-1007
33. Qi Y., Wang J.K., McMillian M., and Chikaraishi D.M. Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. J. Neurosci. 17 4 (1997) 1217-1225
34. Popken G.J., Bunney Jr. W.E., Potkin S.G., and Jones E.G. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc. Natl. Acad. Sci. U. S. A. 97 16 (2000) 9276-9280
35. Rajkowska G., Selemon L.D., and Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry 55 3 (1998) 215-224
36. Reynolds G.P., Beasley C.L., and Zhang Z.J. Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons. J. Neural Transm. 109 5-6 (2002) 881-889
37. Roy M.A., Maziade M., Labbe A., and Merette C. Male gender is associated with deficit schizophrenia: a meta-analysis. Schizophr. Res. 47 2-3 (2001) 141-147
38. Sawa A., and Snyder S.H. Schizophrenia: diverse approaches to a complex disease. Science 296 5568 (2002) 692-695
39. Selemon L.D., Rajkowska G., and Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J. Comp. Neurol. 392 3 (1998) 402-412
40. Son J.H., Kawamata H., Yoo M.S., Kim D.J., Lee Y.K., Kim S., Dawson T.M., Zhang H., Sulzer .D., Yangm L., Beal M.F., Degiorgio L.A., Chun H.S., Baker H., and Peng C. Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons. J. Neurochem. 94 4 (2005) 1040-1053
41. Tamminga C.A. Gender and schizophrenia. J. Clin. Psychiatry 58 Suppl 15 (1997) 33-37
42. Wang H., and Oxford G.S. Voltage-dependent ion channels in CAD cells: a catecholaminergic neuronal line that exhibits inducible differentiation. J. Neurophysiol. 84 6 (2000) 2888-2895
43. Weiss AP., Dewitt I., Goff D., Ditman T., and Heckers S. Anterior and posterior hippocampal volumes in schizophrenia. Schizophr. Res. 73 1 (2005) 103-112
44. Young K.A., Manaye K.F., Liang C., Hicks P.B., and German D.C. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol. Psychiatry 47 11 (2000) 944-953
45. Yuan J., and Yankner B.A. Apoptosis in the nervous system. Nature 407 6805 (2000) 802-809